Die BIOPRO Baden-Württemberg begleitet in den Jahren 2021 und 2022 die Gründung des "Baden-Württemberg-Center for Academic Drug Discovery" (BWCAD2).

Press release - 23/09/2022

Phytopharmaceuticals and valuable plant ingredients - opportunities for industry and agriculture in Baden-Württemberg

The "Phytopharmaceuticals and Valuable Plant Ingredients" initiative aims to make the key economic issue of phytopharmaceuticals more visible in Baden-Württemberg in order to gain a better understanding of the challenges and needs of the state’s pharmaceutical industry. The overall goal is to strengthen the use of secondary plant ingredients in valuable products and build on this to develop opportunities for Baden-Württemberg…

Kooperationsanbahnung ist eine Dienstleistung der BIOPRO Baden-Württemberg für Unternehmen und Forschungseinrichtungen

Installing the next digital generation of computed tomography at various Baden-Württemberg medical centres (PC3)

The Phytopharmaceuticals and Valuable Plant Ingredients initiative aims to further develop phytopharmaceuticals and valuable plant ingredients in Baden-Württemberg.

Press release - 24/04/2024

Strengthening the healthcare sector in the state: BIOPRO Baden-Württemberg networks itself strategically at a European level

BIOPRO has been supporting Baden-Württemberg as a healthcare location for many years and provides important incentives for its further development.  The state company has been a member of the Council of European Bioregions (CEBR) network since April 2024. Within the CEBR, BIOPRO aims to network with European cooperation partners in order to provide even better support for the innovative capacity of the healthcare industry in Baden-Württemberg.

BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024

Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros

The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…

Press release - 29/11/2022

Five European pilot regions are joining forces for the bioeconomy

BIOPRO Baden-Württemberg participates in the Horizon Europe ROBIN project to improve the participation of regional bioeconomy strategies and related policies across Europe.

Data generated by the healthcare system has enormous potential for improving the quality of patient-centered care. As part of the Health Data Scenarios project, Basel Area Business & Innovation worked with numerous experts from industry and academia in 2020 to develop ten scenarios of what future health data ecosystems could look like. These scenarios are now being discussed and validated together with experts and opinion leaders from…